4501 - 4510 of 8571 Results
Title
Year
-
OPENTitle: Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 13End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.003Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.003Citation Count: 6
- Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial2019OPENTitle: Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.006Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.006Citation Count: 55
-
OPENTitle: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 115Issue #:Start Page: 99End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016Best OA location URL: https://doi.org/10.1016/j.cortex.2019.01.016Citation Count: 30
- Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures2019OPENTitle: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.08.006Citation Count: 30
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page: 99End Page: 105Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/jheor.2021.24620Best OA location URL: https://jheor.org/article/24620.pdfCitation Count: 1
- Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation2021OPENTitle: Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain StimulationJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 3Start Page: 239End Page: 241Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20090Best OA location URL: http://e-jmd.org/upload/jmd-20090.pdfCitation Count: 2
- Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease2021OPENTitle: Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00174-xBest OA location URL: https://www.nature.com/articles/s41531-021-00174-x.pdfCitation Count: 36
- Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson’s Disease in a Movement Disorders Clinic2021OPENTitle: Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson’s Disease in a Movement Disorders ClinicJournal Name: Tremor and Other Hyperkinetic MovementsPublisher: Ubiquity Press, Ltd.Vol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5334/tohm.581Best OA location URL: http://tremorjournal.org/articles/10.5334/tohm.581/galley/1510/download/Citation Count: 38
- Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s Disease2021OPENTitle: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s DiseaseJournal Name: NeurologyPublisher: Touch Medical Media, Ltd.Vol: 17Issue #: 1Start Page: 36End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36Best OA location URL: https://touchneurology.com/wp-content/uploads/sites/3/2021/07/touchNEURO_17.1_pp36-47.pdfCitation Count: 1
- The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism2021OPENTitle: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00162-1Best OA location URL: https://www.nature.com/articles/s41531-021-00162-1.pdfCitation Count: 18